Syros Pharmaceuticals Augments Senior Leadership Team

WATERTOWN, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, a therapeutics company focused on discovering and developing novel gene control therapies, today announced the addition of three senior members to the company. Jonathan Garen joins the Company as Chief Business Officer; Christopher Roberts, Ph.D., as Vice President of Chemistry and Early Development; and Colleen DeSimone as Vice President of Finance and Controller.